NCT00142818View on ClinicalTrials.gov

Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Alcohol-Related DisordersAlcoholismCocaine-Related Disorders
Interventions
DRUG

Naltrexone

150 mg daily for males; 100 mg daily for females

DRUG

Modafinil

400 mg daily

DRUG

Placebo

400 mg and/or 100-150 mg placebo pills

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Kyle Kampman

OTHER

NCT00142818 - Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence | Biotech Hunter | Biotech Hunter